Immunitas Therapeutics

Immunitas Therapeutics is a Boston, Massachusetts clinical-stage biotechnology company that discovers and develops novel antibody therapeutics for patients with cancer and autoimmune disease. It was founded by cancer-research and therapeutic-antibody scientists from Dana-Farber Cancer Institute, Mass General Cancer Center, the Broad Institute and MIT, whose single-cell analysis drug-discovery platform identified CD161 as a T-cell target. The lead program, IMT-009, is an anti-CD161 antibody in a Phase 1/2a study in solid tumors and hematological malignancies; a second, preclinical anti-CD161 program (IMT-380) for chronic inflammatory disease was licensed to Boehringer Ingelheim in May 2026. Immunitas publishes no public API, developer portal or machine-readable API contract. Its only public software is open source research tooling from the immunitastx GitHub organization, notably the MIT-licensed Python package monkeybread for analyzing cellular niches in single-cell spatial transcriptomics data.

Immunitas Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Oncology, and Immunology.

Immunitas Therapeutics’ developer surface includes support and 10 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.1/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-14 · rubric v0.22.0

0 APIs

Company Biotechnology Therapeutics Oncology Immunology Autoimmune Disease Single Cell Analysis Spatial Transcriptomics Bioinformatics Open-Source Life Sciences

Kin Score

Kin Score How this is scored →
scored 2026-09-14 · rubric v0.22.0

Composite quality — 11.1/100 · emerging

Contract Quality 0.0 / 21

Developer Ergonomics 0.8 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.3 / 11

Contract Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/immunitas-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Immunitas Therapeutics Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Build 3

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

GitHubRepository

GitHubRepository

Packages

Packages

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 3

Pricing, plans, and the legal terms of use

License

License

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

LinkedIn

Source (apis.yml)

aid: immunitas-therapeutics
name: Immunitas Therapeutics
description: Immunitas Therapeutics is a Boston, Massachusetts clinical-stage biotechnology company that discovers and develops
  novel antibody therapeutics for patients with cancer and autoimmune disease. It was founded by cancer-research and therapeutic-antibody
  scientists from Dana-Farber Cancer Institute, Mass General Cancer Center, the Broad Institute and MIT, whose single-cell
  analysis drug-discovery platform identified CD161 as a T-cell target. The lead program, IMT-009, is an anti-CD161 antibody
  in a Phase 1/2a study in solid tumors and hematological malignancies; a second, preclinical anti-CD161 program (IMT-380)
  for chronic inflammatory disease was licensed to Boehringer Ingelheim in May 2026. Immunitas publishes no public API, developer
  portal or machine-readable API contract. Its only public software is open source research tooling from the immunitastx GitHub
  organization, notably the MIT-licensed Python package monkeybread for analyzing cellular niches in single-cell spatial transcriptomics
  data.
deliveryModel:
  model: unknown
  open_source: unknown
  commercial: true
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - pricing
  - repository-unlicensed
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://static1.squarespace.com/static/6164da62fcac550608373bab/t/6182f75661dfa17d0caa4ec2/1635972950201/immunitas_logo.png?format=1500w
url: https://raw.githubusercontent.com/api-evangelist/immunitas-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-23'
modified: '2026-08-23'
tags:
- Company
- Biotechnology
- Therapeutics
- Oncology
- Immunology
- Autoimmune Disease
- Single Cell Analysis
- Spatial Transcriptomics
- Bioinformatics
- Open-Source
- Life Sciences
tags_raw:
- Company
- Biotechnology
- Therapeutics
- Oncology
- Immunology
- Autoimmune Disease
- Single-Cell Analysis
- Spatial Transcriptomics
- Bioinformatics
- Open Source
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: License
  name: MIT
  url: https://github.com/immunitastx/monkeybread/blob/main/LICENSE
- type: Website
  url: https://www.immunitastx.com/
- type: PrivacyPolicy
  url: https://www.immunitastx.com/privacy-policy
- type: TermsOfService
  url: https://www.immunitastx.com/terms-and-conditions
- type: Support
  url: https://www.immunitastx.com/home#contact
- type: GitHubOrganization
  url: https://github.com/immunitastx
- type: LinkedIn
  url: https://www.linkedin.com/company/immunitas/
- type: GitHubRepository
  url: https://github.com/immunitastx/monkeybread
- type: Packages
  url: packages/immunitas-therapeutics-packages.yml
- type: DomainSecurity
  url: security/immunitas-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/immunitas-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-23'
  status: minimal
  artifacts_added: 4
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Immunitas Therapeutics is a clinical-stage antibody drug developer (IMT-009, anti-CD161) whose entire public web
    presence is a four-page Squarespace marketing site — its own sitemap.xml lists only /home, /privacy-policy, /terms-and-conditions
    and /rdday, with no developer, docs or API page anywhere — so the only machine-readable software it publishes is the MIT-licensed
    monkeybread Python package for spatial-transcriptomics analysis, which calls no Immunitas service.
  evidence:
  - url: https://www.immunitastx.com/sitemap.xml
    status: 200
  - url: https://www.immunitastx.com/openapi.json
    status: 404
  - url: https://www.immunitastx.com/.well-known/agent-card.json
    status: 404
  - url: https://www.immunitastx.com/llms.txt
    status: 404
  - url: https://pypi.org/pypi/monkeybread/json
    status: 200
  checked: '2026-08-23'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/immunitas-therapeutics"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/immunitas-therapeutics/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/immunitas-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.